A Systematic Review and Meta-analysis of Chemoablation for Non–muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

A Systematic Review and Meta-analysis of Chemoablation for Non–muscle-invasive Bladder Cancer

Published:2022-12 Issue: Volume: Page:
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Yanagisawa Takafumi,Quhal Fahad,Kawada Tatsushi,Mostafaei Hadi,Motlagh Reza Sari,Laukhtina Ekaterina,Rajwa Pawel,Deimling Markus von,Bianchi Alberto,Pallauf Maximilian,Majdoub Muhammad,Pradere Benjamin,Moschini Marco,Karakiewicz Pierre I.,Teoh Jeremy Yuen-Chun,Miki Jun,Kimura Takahiro,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology

Reference56 articles.

1. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk;Eur Urol,2022

2. Prognostic value of the WHO1973 and WHO2004/2016 classification systems for grade in primary Ta/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel study;van Rhijn;Eur Urol Oncol,2021

3. Deep learning-based recalibration of the CUETO and EORTC prediction tools for recurrence and progression of non-muscle-invasive bladder cancer;Jobczyk;Eur Urol Oncol,2022

4. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness;Shariat;Mod Pathol,2007

5. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature;Crivelli;Eur Urol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

2. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG);European Urology Oncology;2024-08

3. Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non–muscle-invasive Bladder Cancer;European Urology Oncology;2024-06

4. Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial;European Urology;2023-11

5. Editorial Comment;Journal of Urology;2023-10